UPL has reported results for the fourth quarter and year ended March 31, 2016.
The company has posted over two fold jump in its net profit at Rs 205.67 crore for the quarter ended March 31, 2016 as compared to Rs 75.74 crore for the same quarter in the previous year. Total income of the company has increased by 27.67% at Rs 1652.13 crore for quarter under review as compared to Rs 1294.03 crore for the quarter ended March 31, 2015.
On consolidated basis, the company has posted a rise of 25.44% in its net profit after taxes, minority interest and share of profit of associates at Rs 552.02 crore for the quarter ended March 31, 2016 as compared to Rs 440.06 crore for the corresponding quarter in the FY15. Total income of the company increased by 23.43% at Rs 4412.6 crore for quarter under review as compared to Rs 3574.97 crore for the same quarter ended previous year.
For the year ended March 31, 2016, the company has posted a rise of 52.31% in its net profit at Rs 705.71 crore as compared to Rs 463.33 crore for the same period in the previous year. Total income of company increased 15.12% at Rs 6441.31 crore for year under review as compared to Rs 5595.29 crore for the period ended March 31, 2015.
For the year ended March 31, 2016, on the consolidated basis, the company has posted rise of 13.53% in its net profit after taxes, minority interest and share of profit of associates at Rs 1298.79 crore as compared to Rs 1144.03 crore for the same period in the previous year. Total income of company has increased by 10.97% at Rs 13413.24 crore for year under review as compared to Rs 12087.69 crore for the period ended March 31, 2015.
| Company Name | CMP |
|---|---|
| UPL | 665.00 |
| PI Industries | 3144.45 |
| Bayer CropScience | 4900.45 |
| Sharda Cropchem | 1109.70 |
| Sumitomo Chemical | 441.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: